601 Broadway

Seattle, Washington 98122

0 studies enrolling now · 2 studies all time

What they study most

Primary Fibromyalgia

Studies at this site

• 12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients — Completed
• BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT) — Completed